269 related articles for article (PubMed ID: 16469486)
1. [Central venous totally implantable access for high dose chemotherapy in children].
Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
[TBL] [Abstract][Full Text] [Related]
2. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs).
Nam SH; Kim DY; Kim SC; Kim IK
Pediatr Blood Cancer; 2010 Apr; 54(4):546-51. PubMed ID: 19967773
[TBL] [Abstract][Full Text] [Related]
3. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
5. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.
Biffi R; Pozzi S; Agazzi A; Pace U; Floridi A; Cenciarelli S; Peveri V; Cocquio A; Andreoni B; Martinelli G
Ann Oncol; 2004 Feb; 15(2):296-300. PubMed ID: 14760125
[TBL] [Abstract][Full Text] [Related]
6. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
7. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
[TBL] [Abstract][Full Text] [Related]
8. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients.
Fischer L; Knebel P; Schröder S; Bruckner T; Diener MK; Hennes R; Buhl K; Schmied B; Seiler CM
Ann Surg Oncol; 2008 Apr; 15(4):1124-9. PubMed ID: 18214621
[TBL] [Abstract][Full Text] [Related]
9. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
11. Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells.
Lazarus HM; Trehan S; Miller R; Fox RM; Creger RJ; Raaf JH
Bone Marrow Transplant; 2000 Apr; 25(7):779-85. PubMed ID: 10745265
[TBL] [Abstract][Full Text] [Related]
12. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
13. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
Dickinson MG; Schölvinck EH; Boonstra A; Vonk-Noordegraaf A; Snijder RJ; Berger RM
J Heart Lung Transplant; 2009 Mar; 28(3):273-9. PubMed ID: 19285620
[TBL] [Abstract][Full Text] [Related]
14. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach.
Chen SY; Lin CH; Chang HM; Hsu HM; Yu JC
J Surg Oncol; 2008 Sep; 98(3):197-9. PubMed ID: 18704915
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
Magagnoli M; Masci G; Castagna L; Pedicini V; Poretti D; Morenghi E; Brambilla G; Santoro A
Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
[TBL] [Abstract][Full Text] [Related]
16. Trigger arrhythmia to confirm the position of totally implantable access ports (TIAP).
Hsieh HF; Yu JC; Chuang CH; Wu HS; Tsai YC; Lin CH
J Surg Oncol; 2007 Oct; 96(5):436-7. PubMed ID: 17372925
[TBL] [Abstract][Full Text] [Related]
17. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous placement of femoral central venous catheter in patients undergoing transplantation of bone marrow.
Lazarus HM; Creger RJ; Bloom AD; Shenk R
Surg Gynecol Obstet; 1990 May; 170(5):403-6. PubMed ID: 2183372
[TBL] [Abstract][Full Text] [Related]
19. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
20. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
